Use of brain natriuretic peptide and bioimpedance to guide therapy in heart failure patients

Fluid Overload

Volumn , Issue , 2010, Pages 209-216

  Valle, Roberto ^a   Aspromonte, Nadia ^b  

^a Ospedale Civile   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIAGNOSTIC AGENT;

BLOOD; HEART FAILURE; HUMAN; IMPEDANCE; METABOLIC DISORDER; METABOLISM; REVIEW;

BIOLOGICAL MARKERS; ELECTRIC IMPEDANCE; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; WATER-ELECTROLYTE IMBALANCE;

EID: 77955481884     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783805594172.ch18     Document Type: Chapter

References (29)

1. Nieminen MS, Bohm M, Cowie MR, et al: Executive summary of the guidelines on the diagnosis and treatment of acute heart fail-ure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416.
2. Haldeman GA, Croft JB, Giles WH, Rashidee A: Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999;137:352-360.
3. Stewart S, Jenkins A, Buchan S, et al: The current cost of heart failure to the National Health Service in the U.K. Eur J Heart Fail 2002;4:361-371.
4. McAlister FA, Stewart S, Ferrua S, McMurray JJ: Multidisciplinary strategies for the man-agement of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44:810-819.
5. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, for the ADHERE Scientific Advisory Committee and Investigators: Clinical presentation, manage-ment, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47:76-84.
6. Kinnunen P, Vuolteenaho O, Ruskoaho H: Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocar-dium: effect of stretching. Endocrinology 1993;132:1961-1970.
7. Kazanegra R, Cheng V, Garcia A, et al: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart fail-ure: a pilot study. J Card Fail 2001;7:21-29.
8. Johnson W, Omland T, Hall C, et al: Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002;39:1623-1629.
9. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A: N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-2174.
10. Androne AS, Hryniewicz K, Hudaihed A, Manciri D, Lamanca J, Katz SD: Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 2004; 93:1254-1259.
11. Gheorghiade M, Pang PS: Are BNP changes during hospitalization for heart failure a reli-able surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol 2009;53:2349-2352.
12. Maisel A, Mueller C, Adams K Jr, et al: State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008; 10:824-839.
13. Maisel A: Practical approaches to treating patients with acute decompensated heart fail-ure. J Card Fail 2001;7:13-17.
14. Valle R, Aspromonte N, Giovinazzo P, et al: B-type natriuretic peptide-guided treatment for predicting outcome in patients hospital-ized in sub-intensive care unit with acute heart failure. J Card Fail 2008;14:219-224.
15. Logeart D, Thabut G, Jourdain P, et al: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43: 635-641.
16. Cournot M, Mourre F, Castel F, Ferrières J, Destrac S: Optimization of the use of B-type natriuretic peptide levels for risk stratifica-tion at discharge in elderly patients with dec-ompensated heart failure. Am Heart J 2008; 155:986-991.
17. Faggiano P, Valle R, Aspromonte N, et al: How often we need to measure brain natri-uretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol 2009, Epub ahead of print.
18. Paterna S, Di Pasquale P, Parrinello G, et al: Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory conges-tive heart failure: a double-blind study. J Am Coll Cardiol 2005;45:1997-2003.
19. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM: Patterns of weight change preceding hospitalization for heart failure. Circulation 2007;116:1549-1554
20. Chakko S, Woska D, Martinez H, et al: Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inap-propriate care. Am J Med 1991;90:353-359.
21. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL: Increased central venous pressure is associ-ated with impaired renal function and mor-tality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-588.
22. Drazner MH, Rame JE, Stevenson LW, Dries DL: Prognostic importance of elevated jugu-lar venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574-581.
23. Bioelectrical impedance analysis in body composition measurement. Proceedings of a National Institutes of Health Technology Assessment Conference. Bethesda, Maryland, December 12-14, 1994. Am J Clin Nutr 1996;64(suppl):387S-532S.
24. Sergi G, Bussolotto M, Perini P, et al: Accuracy of bioelectrical impedance analysis in estimation of extracellular space in healthy subjects and in fluid retention states. Ann Nutr Metab 1994;38:158-165.
25. Piccoli A, Rossi B, Pillon L, Bucciante G: A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int 1994;46:534-539.
26. Coodley EL, Segal JL, Smith DH, Neutel JM: Bioelectrical impedance analysis as an assess-ment of diuresis in congestive heart failure. Ann Pharmacother 1995;29:1091-1095.
27. Parrinello G, Paterna S, Di Pasquale P, et al: The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 2008;14:676-686.
28. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
29. Valle R, Aspromonte N, Carbonieri E, et al: Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study. Int J Cardiol 2008;126:400-406.